发明名称 |
DOSAGE REGIME OF FUSION COMPOUNDS |
摘要 |
Use of at least one fusion protein comprising at least one Type 1 Ribosome Inactivating Protein, polypeptide B; and at least one polypeptide A which is a antimicrobial peptide and/or at least one Cationic AntiMicrobial Peptide, polypeptide C for the preparation of a medicament for treating a cancer and/or a microbial infection wherein the medicament is suitable for oral administration pre food intake. |
申请公布号 |
EP2864361(A4) |
申请公布日期 |
2016.06.01 |
申请号 |
EP20130808945 |
申请日期 |
2013.06.25 |
申请人 |
BIOVALENCE SDN. BHD. |
发明人 |
SEKARAN, SHAMALA DEVI K C;ROTHAN, HUSSIN A.;UNG, ENG HUAN;ABU BAKAR, AG. MUHAMMAD SAGAF |
分类号 |
C07K19/00;A61K38/00;A61P31/00;A61P35/00 |
主分类号 |
C07K19/00 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|